List of Excipients in API cysteamine bitartrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cysteamine bitartrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mylan Pharmaceuticals Inc | CYSTAGON | cysteamine bitartrate | 0378-9040 | AMMONIA | |
| Mylan Pharmaceuticals Inc | CYSTAGON | cysteamine bitartrate | 0378-9040 | CROSCARMELLOSE SODIUM | |
| Mylan Pharmaceuticals Inc | CYSTAGON | cysteamine bitartrate | 0378-9040 | FERROSOFERRIC OXIDE | |
| Mylan Pharmaceuticals Inc | CYSTAGON | cysteamine bitartrate | 0378-9040 | GELATIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for cysteamine bitartrate
Excipient focus: AMMONIA
cysteamine bitartrate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
cysteamine bitartrate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
cysteamine bitartrate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
cysteamine bitartrate drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
cysteamine bitartrate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
cysteamine bitartrate drug variants containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
cysteamine bitartrate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
cysteamine bitartrate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
cysteamine bitartrate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
cysteamine bitartrate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
cysteamine bitartrate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cysteamine bitartrate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cysteamine bitartrate | 0378-9040 |
| >Company | >Ingredient | >NDC |
cysteamine bitartrate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch